in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Codexis narrows loss
1:24 AM MDT | May 8, 2014 | Deepti Ramesh
Codexis (Redwood City, CA), a developer of biocatalysts for the pharmaceutical and fine chemical industries, reports a net loss of $6.37 million in the first quarter of 2014 compared with a net loss of $9.62 million in the first quarter of 2013. First-quarter sales decreased 38.3%, to $7.07 million. “Codexis is off to a solid start in 2014, now fully focused on our core strategy of growing our biocatalyst business serving pharmaceutical drug development and manufacturing,” says John Nicols, president and CEO of Codexis. “Revenues and gross...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee